The launch of Takeda's Qdenga vaccine is a key milestone in Malaysia's integrated dengue management.
Left to right: Dr Goh Choo Beng (Head of Medical Affairs, Takeda India & Southeast Asia), Professor Datuk Dr Zulkifli Ismail (Consultant Paediatrician and Paediatric Cardiologist, Chairman of Dengue Prevention Advocacy Malaysia), Dr Lynette Moey (Country General Manager, Takeda Malaysia & Singapore), Sony Paul (Vaccine Franchise Head, Takeda Malaysia & Singapore)
Dr Goh Choo Beng presents the clinical data on the dengue vaccine
Questions and answers session with members of the audience